相似文献
1
[Pharmacological prevention of coronary thrombosis].
Pol Tyg Lek. 1987 Jun 29;42(26):795-801.
2
Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis.
Trans Assoc Am Physicians. 1993;106:110-9.
3
[Primary prevention of coronary heart disease with aspirin].
Z Kardiol. 2004;93 Suppl 2:II33-6. doi: 10.1007/s00392-004-1206-6.
4
[Antiplatelet therapy during coronary endoprosthesis placement].
Arch Mal Coeur Vaiss. 1996 Nov;89(11 Suppl):1515-20.
5
Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation.
Am Heart J. 1999 Feb;137(2):274-83. doi: 10.1053/hj.1999.v137.91540.
6
[Thrombophilia in patients with arterial occlusive diseases and its therapeutic modification].
Vasa Suppl. 1991;32:300-4.
7
Problem with aspirin as antithrombotic agent in coronary artery disease.
Lancet. 1988 Apr 23;1(8591):937-8. doi: 10.1016/s0140-6736(88)91742-4.
8
Usefulness of aspirin for coronary artery disease.
Am J Cardiol. 1988 Mar 1;61(8):637-40. doi: 10.1016/0002-9149(88)90780-1.
9
A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
J Pharmacol Exp Ther. 2001 Feb;296(2):567-72.
10
Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Am Heart J. 2001 Aug;142(2):E1. doi: 10.1067/mhj.2001.116485.
Zotero 插件